Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Clinical trial NCT02349048 · COMPLETED
Trial details
- NCT number
- NCT02349048
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-02-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.